Source: BioSpace

RA Capital: Synthego Raises $100 Million to Accelerate CRISPR Platform Scale-up in Response to Growing Demand

Synthego, the genome engineering company, today announced that it raised $100 million in a Series D financing led by new investor Wellington Management, co-led by RA Capital Management and 8VC.

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Est. Annual Revenue
Est. Employees
Peter Kolchinsky's photo - Managing Partner of RA Capital

Managing Partner

Peter Kolchinsky

CEO Approval Rating

68/100

RA Capital Management is a venture capital firm that invests in healthcare and life-sciences companies. Read more